Longboard Pharmaceuticals Profit Margin

Longboard Pharmaceuticals (LBPH) currently reports a profit margin of -954300.0% as of September 2024. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Longboard Pharmaceuticals's profit margin history and peer comparisons.

Longboard Pharmaceuticals's profit margin of -954300.0% is lower than the Healthcare sector average of 14.34%. That is roughly 6652694.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Longboard Pharmaceuticals's current -954300.0% should be judged against Healthcare norms (sector average: 14.34%) and against LBPH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -954300.0%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Longboard Pharmaceuticals, and consider following LBPH for alerts when major investors trade the stock.

Longboard Pharmaceuticals is classified in the Healthcare sector. On profit margin, it currently shows -954300.0% versus a sector average near 14.34%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBPH with unrelated industries.